Please login to the form below

Not currently logged in
Email:
Password:

Merck Serono CEO joins L’Oreal board

Belén Garijo named independent director at beauty company

Belén Garijo Belén Garijo – the present CEO of Merck Serono – has been appointed to the board of beauty company L'Oreal.

Garijo, who took up her current role at pharma company Merck Serono in September last year, will now also serve as an independent director at L'Oreal for a period of four years.

Garijo joined Merck Serono as chief operating officer in 2011. In addition to her current role as CEO she has served as interim global head of R&D at parent company Merck KGaA since the departure of Annalisa Jenkins earlier this year.

Before joining Merck, Garijo served as senior VP, global operations region Europe at Sanofi. During her time at Sanofi, she also took on the role of global integration leader for the company's acquisition of the biotech Genzyme.

Prior to her career in the industry Garijo worked for six years as a practicing physician.

23rd April 2014

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PRMA Consulting Ltd

PRMA Consulting is an independent consultancy solving some of the most challenging pricing, reimbursement and market access issues facing international...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics